Smad7, as a vital inhibitor of the TGFβ signaling pathway, can suppress the progression of HCC, and its deficiency accelerates tumorigenesis of HCC (Wang et al., 2013). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.